Latest News

NIH launches early Ebola treatment trial

A phase 1 study of a potential new Ebola treatment has begun at the NIH, examining the safety of monoclonal antibody mAb114 in healthy volunteers...

Conference Coverage

HBV birth dose predicts vaccine adherence

Infants who do not receive the hepatitis B vaccine birth dose are less likely to be up-to-date on recommended vaccines by 19 months, results from...